Dashboard
Manage Tickers

PFE


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Reported Earlier, 'Pfizer Matches Novo Bid...
11/06/2025 09:15:19

https://www.ft.com/content/ae3297f3-4dd1-4c8a-b9c5-9c3717d34c52 

Core News & Articles
Reported Earlier, Metsera Issues Statement...
11/06/2025 08:41:37

"Metsera is gratified by the Delaware Court of Chancery's decision to deny Pfizer's request for a temporary restrai...

pfizer-responds-to-delaware-chancery-court-ruling-said-we-remain-confident-in-the-merits-of-our-claims-and-our-belief-that-metsera-has-acted-in-breach-of-its-contractual-obligations
Pfizer Responds To Delaware Chancery Court...
11/05/2025 22:13:12

Core News & Articles
The Wall Street Journal Reported Pfizer Pr...
11/05/2025 21:55:02

Core News & Articles
Novo Nordisk, In A Statement, Says Its Met...
11/05/2025 20:26:03

Core News & Articles
Watching Novo Nordisk, Pfizer, Metsera; Tr...
11/05/2025 20:25:21

Core News & Articles
Metsera Estimates Value Of Pfizer's Latest...
11/05/2025 19:11:32

-Reuters Citing Metsera Letter To Court

Core News & Articles
Pfizer Has Removed Conditions On Sale Of A...
11/05/2025 19:10:18

-Reuters Citing Letter To Court

Core News & Articles
10 Health Care Stocks Whale Activity In To...
11/05/2025 17:35:20

novo-pfizer-are-battling-to-buy-the-future-of-weight-loss--but-viking-already-owns-it
Novo, Pfizer Are Battling To Buy The Futur...
11/04/2025 20:04:42

Viking Global's $45 million investment in Metsera, a biotech company is caught in a bidding war between Pfizer and Novo Nor...

pfizer-novo-nordisk-intensify-fight-for-metsera-as-buyout-offers-continue-to-climb
Pfizer, Novo Nordisk Intensify Fight For M...
11/04/2025 19:45:55

Novo Nordisk boosts its Metsera bid to $62.20 per share, valuing the company at $10 billion and outbidding Pfizer in the escala...

pfizer-q3-revenue-trends-remain-uneven-cost-cuts-drive-earnings
Pfizer Q3 Revenue Trends Remain Uneven, Co...
11/04/2025 18:25:49

Pfizer revenue trends remained uneven in the third quarter, the company exhibited "continued cost discipline," accordin...

palantir-weighs-on-wall-street-bitcoin-slumps-5-whats-moving-markets-tuesday
Palantir Weighs On Wall Street, Bitcoin Sl...
11/04/2025 18:22:32

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, o...

Core News & Articles
Pfizer CEO Says Our Bid For Metsera Has Ta...
11/04/2025 15:52:10

-Reuters Citing Conf. Call

dow-dips-over-400-points-pfizer-earnings-top-estimates
Dow Dips Over 400 Points; Pfizer Earnings ...
11/04/2025 14:53:19

pfizers-core-drugs-offset-covid-revenue-drop-lifts-2025-profit-outlook-despite-tariffs
Pfizer's Core Drugs Offset COVID Revenue D...
11/04/2025 14:22:21

Pfizer beat Q3 estimates with 87 cents EPS, raised 2025 profit guidance, as Eliquis and Vyndaqel growth offset declining COVID ...

Core News & Articles
Pursuant To Pfizer Merger Agreement, Metse...
11/04/2025 14:12:57

Core News & Articles
Metsera Receives Amended Proposal From Nov...
11/04/2025 14:11:56

pfizer-q3-revenues-higher-for-eliquis-vyndaqel-and-nurtec-odtvydura-offset-by-lower-revenues-for-paxlovid-and-comirnaty
Pfizer Q3 Revenues Higher For Eliquis, Vyn...
11/04/2025 11:48:54

pfizer-raises-fy2025-adj-eps-guidance-from-290-310-to-300-315-vs-304-est-affirms-fy2025-sales-guidance-of-61000b-64000b-vs-62879b-est
Pfizer Raises FY2025 Adj EPS Guidance from...
11/04/2025 11:45:49

Pfizer (NYSE:PFE) raises FY2025 Adj EPS guidance from $2.90-$3.10 to $3.00-$3.15 vs $3.04 analyst estimate. Affirms FY2025 sale...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION